Showing results (571-580 of 865) with videos related to
Sort By:
Pageof 87
European Journal of Cancer (Oxford, England : 1990)|March 12, 2014
The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II studyD J Watkins, N Starling, D Cunningham, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2002
Blood extraction from lancet wounds using vacuum combined with skin stretchingDavid D Cunningham, Timothy P Henning, Eric B Shain, et al.European Journal of Biochemistry|January 5, 1999
X-ray crystal structure of the Desulfovibrio vulgaris (Hildenborough) apoflavodoxin-riboflavin complexM A Walsh, A McCarthy, P A O'Farrell, et al.Journal of Affective Disorders|March 14, 2024
Discrimination and perinatal depressive symptoms: The protective role of social support and resilienceClaire Masters, Jessica B Lewis, Ashley Hagaman, et al.Maternal and Child Health Journal|August 4, 2016
Group Prenatal Care Attendance: Determinants and Relationship with Care SatisfactionShayna D Cunningham, Stephanie Grilo, Jessica B Lewis, et al.Journal of Affective Disorders|January 25, 2025
Association between prenatal depressive symptoms and receipt of recommended maternal and infant care postpartumClaire Masters, Rogie Royce Carandang, Janet A Rojina, et al.British Journal of Cancer|April 7, 2005
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphomaM Ng, J Waters, D Cunningham, et al.Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphomaN L Gilchrist, J Caldwell, I D Watson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trialsE Mitry, J-Y Douillard, E Van Cutsem, et al.American Journal of Surgery|June 1, 1997
Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancerJ D Cunningham, G K Schwartz, M Karpeh, et al.Pageof 87